|
Somlo, George; Frankel, Paul H; Arun, Banu K et al. (2017) Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083. Clin Cancer Res 23:4066-4076
|
|
Kiesel, Brian F; Parise, Robert A; Tjørnelund, Jette et al. (2013) LC-MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma. J Pharm Biomed Anal 81-82:89-98
|
|
Kirschbaum, Mark H; Goldman, Bryan H; Zain, Jasmine M et al. (2012) A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517. Leuk Lymphoma 53:259-62
|
|
Kindler, Hedy L; Karrison, Theodore G; Gandara, David R et al. (2012) Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol 30:2509-15
|
|
El-Khoueiry, A B; Ramanathan, R K; Yang, D Y et al. (2012) A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. Invest New Drugs 30:1175-83
|
|
Mackay, H J; Buckanovich, R J; Hirte, H et al. (2012) A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. Gynecol Oncol 125:136-40
|
|
Kirschbaum, Mark; Frankel, Paul; Popplewell, Leslie et al. (2011) Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma. J Clin Oncol 29:1198-203
|
|
Ramalingam, Suresh S; Davies, Angela M; Longmate, Jeffrey et al. (2011) Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003). J Thorac Oncol 6:1741-5
|
|
Lara Jr, Primo N; Longmate, Jeff; Reckamp, Karen et al. (2011) Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial. Clin Lung Cancer 12:33-7
|
|
Somlo, George; Lashkari, Ashkan; Bellamy, William et al. (2011) Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial. Br J Haematol 154:533-5
|
Showing the most recent 10 out of 25 publications
